Purple Biotech’s CEO Gil Efron is featured in Pharma’s Almanac sharing his insights in a Q&A executive interview. Read the full Q&A here.
in Mar 27, 2023
EXECUTIVE INTERVIEW – Purple Biotech Ltd.: Developing First-In-Class Oncology Therapies
Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland.
in Mar 20, 2023
March 20 2023 at 8:00 am – March 22 at 5:00 pm – UTC+0
Purple Biotech CEO Gil Efron is featured in Drug Development and Delivery Magazine in a Q&A executive interview. Read the full interview.
in Mar 14, 2023
EXECUTIVE INTERVIEW – Purple Biotech Ltd.: Developing First-In-Class Oncology Therapies
Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”.
in Feb 01, 2023
February 6 2023 at 8:00 am – February 7 at 5:00 pm – UTC+0
Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023
in Dec 11, 2022
January 9 2023 at 8:00 am – January 12 at 5:00 pm – UTC+0
Purple Biotech to participate and Present at the Jefferies London Healthcare Conference
in Nov 11, 2022
November 15 2022 at 8:00 am – November 17 at 5:00 pm – UTC+0
Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis
in Nov 08, 2022
November 14 2022 at 8:00 am – November 17 at 5:00 pm – UTC+0
Purple Biotech to participate in a leadership call by Chardan Capital Markets LLC. – Click here to replay
in Nov 01, 2022
November 8 2022 at 8:00 am – 5:00 pm – UTC+0